信貸個人化推薦Asianet Newsable on MSN.com - 1 天前查看原文
TransCode Stock Rallies On Promising Metastatic Cancer Drug Trial: Retail Sees More Upside
TransCode Therapeutics shares surged nearly 39% after reporting promising Phase 1a trial results for its metastatic cancer drug TTX-MC138, with strong retail interest and no major safety concerns.
貼文中的美股標籤
